http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2405120-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c25cf93c5ac5c1d1eb7d84724a7c337 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2402 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24 |
| filingDate | 2001-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2471389d7b7cd10a3c7cb323862efb |
| publicationDate | 2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2405120-A1 |
| titleOfInvention | Expression system for efficiently producing clinically effective lysosomal enzymes (glucocerebrosidase) |
| abstract | The invention as described herein relates to the efficient production of recombinant, clinically effective lysosomal enzymes using a transformed inse ct cell expression system. For example, to create the expression system of the invention, any insect cell can be transfected with a plasmid comprised of a gene encoding the human glucocerebrosidase gene and genetic elements that enhance its expression. The insect cell transfected with the plasmid encodin g glucocerebrosidase secretes synthesized glucocerebrosidase into its growth media. The recombinantly produced clinically effective glucocerebrosidase produced by the insect cell expression system can be used to treat Gaucher's disease. |
| priorityDate | 2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 705.